This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
SAP Struggles Against its New Cloud Competitors: Chart of the Day

SAP AG has run into some problems, and it comes at a bad time for any Silicon Valley-based companies to run into trouble with shareholders.

Navigating United Continental, Delta, American, & the Volatility Play

Volatility is back in the picture for U.S. markets, and in a big way.

European Stocks Fall; Rocket Burns Out Fuse After Top-of-Range Pricing

European stock indices decline, taking their cue from a weak day of trading in Asia and heavy falls on Wall Street on Wednesday.

What to Watch on Wall Street for Thursday, October 2nd 2014

For Thursday, Oct. 2 we keep our eyes on biotech stocks as shares of Tekmira Pharmaceuticals surged on Wednesday after the first confirmed case on American soil.

Southwest Airlines Stock Sank on U.S. Ebola Outbreak Fears

After the first case of Ebola in the U.S. was confirmed, shares of Southwest Airlines fell on Wednesday making it TheStreet's Move of the Day.

Real Money Previews

Death Cross? Don't Abandon the Russell 2000 Index Just Yet

The small-cap stock index has fallen to 'death cross' territory but that might be changing soon.

Jim Cramer on the Markets: Industrials Tell Us Things Have Worsened

Industrials are telling us business is tougher.

Jim Cramer on the Markets: Why the IPO Deluge Must Stop

The deal parade is putting pressure on the market.

Mad Money Recap

'Mad Money' Lightning Round: I'm Taking a Pass on New York Community Bancorp

Cramer likes Salix Pharmaceuticals but would like Lazard better at a 3% yield.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

4 Bargain Bin Stocks to Pad Your Portfolio in October

While 'cheap' stocks have been harder to find lately, they're still out there. Here are five stock bargains to consider.

2 Oversold Stocks Under $10 Ready to Bounce Higher

Oversold can always get more oversold, but it's also an area from which a stock can experience a powerful bounce higher if the sellers have become exhausted.

4 Stocks Under $10 Making Big Moves Higher

hen a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

MainStreet

Senior Citizens Now Have $18.2 Billion in Student Loan Debt -- And Growing

When the topic of student loan debt is brought up, most people think of stressed out Millennials or Generation X-ers. However, the problem is also increasingly impacting older Americans.

How to Dispute Items on Your Credit Report and Win: Use This Strategy

As many as 40 million Americans have errors on their credit report. Unfortunately, once you find the errors, it’s hard to know how to go about removing them.

10 Questions a Career Coach Says Will Help You Ace Job Interviews

Any anxious job applicant fares worse than candidates who have a good grip on their nerves, who get more job offers and can even get more money.

Why Most Millennials Don't Have a Credit Card: Fear of the Plastic

Most Millennials are ditching credit cards because they're already saddled with debts, such as from student loans. But they're gravitating toward riskier debit cards and not building a credit history.

Do Development Incentives Work to Bring Businesses to Certain Locales?

Local governments certainly seem to think so. New research suggests otherwise.

Biotech

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job

Martin is super smart and will be a great asset somewhere, but he is not a CEO. I wish him the best.

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?

Beyond Wall St.

Deal News

Pet Retailers TABcom, Drs. Foster & Smith Hit the Block

With a pack of deals for makers of products for humans' furry friends, e-commerce players are also hitting the auction block.

Healthcare Assets Leading Indian Inbound Deals, Plus IPOs

Healthcare Global, an Indian cancer company with more than $200 million in revenue, is readying itself for a public market offering there.

Room for Upside in Angie's List Stock Amid Takeover Rumors

One analyst thinks Lowe's or Home Depot could bid up to $13 per share--well above consumer website's current price, which is up 20% on the day despite broad market declines.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer Tells Stephanie Link Money Will Go to Secular Growth Trends

Consumer's money will go to places where there are secular growth trends, self-help and improvement says Jim Cramer.

Herb Greenberg

Herb Greenberg: Too Soon to Question GoPro's Earnings Quality?

Keep these points from its most recent quarter in mind.

Stephanie Link

Jim Cramer Tells Stephanie Link Money Will Go to Secular Growth Trends

Consumer's money will go to places where there are secular growth trends, self-help and improvement says Jim Cramer.

Chris Ciaccia

How Elon Musk Continues to Pull Rabbits Out of a Hat, As Tesla Is Set to 'Unveil the D'

Tesla CEO Elon Musk continues to set the world ablaze, as the enigmatic leader unveiled that Tesla has more to show off than is currently known.

Adam Feuerstein

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Dan Freed

Why Fannie Mae and Freddie Mac Investors May Want to Wait to Sell

Fannie Mae and Freddie Mac investors dumped their holdings following an unfavorable legal decision. But some investment pros think it might be wiser to wait.

Ted Reed

Eyes on Delta as Airline Shares Face Correction, Ebola Scare

Delta, American, Southwest, JetBlue and Spirit shares all gave up more than 3% on Wednesday. Delta reports September unit revenue on Thursday.

Leon Lazaroff

TV Ratings Off to Bad Start Amid Surge in Digital Video

Television executives have downplayed the summer ratings slip, but the fall viewing season only reinforces the view that broadcast and pay-TV viewing is declining.

Submit an article to us!
DOW 16,804.71 -238.19 -1.40%
S&P 500 1,946.16 -26.13 -1.32%
NASDAQ 4,422.0850 -71.3050 -1.59%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs